SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-109836
Filing Date
2008-05-09
Accepted
2008-05-09 16:28:27
Documents
7
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 448516
2 THIRD AMENDMENT DATED DECEMBER 13, 2007, TO LEASE AGREEMENT dex10258.htm EX-10.258 32445
3 SECOND AMENDMENT DATED JANUARY 10, 2008, TO LEASE AGREEMENT dex10259.htm EX-10.259 32810
4 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9538
5 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9565
6 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 2674
7 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 2671
  Complete submission text file 0001193125-08-109836.txt   539649
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27570 | Film No.: 08818822
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 9